Northstar42,
I've been reading your posts and am impressed with your presentation. Your mention of being supportive re: Leronlimab gaining FDA approval is a positive factor, but you still appear as primarily a "front man" for the 13d group. That's unfortunate but hopefully not "engraved in stone." Nader has been over-vilified and it appears many are beating drums without a full-spectrum CYDY information base. I've utilized a decent portion of my "speculative stock money" on this company, especially its product and also its leader. Yes, he's not perfect, but I respect him and believe he is truly trying to do something good. The 13d set, on the other hand, is to my mind - not an adequate replacement. I still must await the words from the mouths of the 13d'ers, but please be advised...I will not "trade-down."
While it seems you are "of the 13d group," I hope you as well, will keep an open mind. If your 13d folks run a course similar to Nader's they're going to run into some of the same visible and invisible obstacles. In a cursory examination of their skill sets, I don't see anything to convince myself of a more positive outcome.
On the other hand, if 13d's role is just to capitulate and allow BP to control Leronlimab (and postentially permanently remove Leronlimag from the market place), I cannot, in good conscience, be party to such.
It's very unfortunate the 13d group opted to enter the arena in an extremely adversarial manner. I think win-win alliances are always preferable to generating new adversaries. Alas, the choice has been made, now each of us must consider the alternative(s) and ultimately make a decision. You impress me as an astute observer...perhaps you still have an open mind as well...
With regards,
Learning53
